Will Soleno's stock price surpass its current 52-week high by December 31, 2024? | Binary | | | 3 months ago | |
Will FDA approve Soleno's DCCR tablets for Prader-Willi Syndrome by end of 2024? | Binary | | | 3 months ago | |
Will the FDA approve Soleno's NDA for DCCR for Prader-Willi Syndrome by December 27, 2024? | Binary | | | 4 months ago | |
How will Soleno's stock perform relative to its sector by December 31, 2024? | Categorical | | | 3 months ago | |
Will Soleno initiate a new clinical trial for DCCR tablets by June 30, 2025? | Binary | | | 3 months ago | |
What will be the outcome of Soleno's DCCR tablets FDA review by March 31, 2025? | Categorical | | | 3 months ago | |
What will be the outcome of Soleno's DCCR FDA review by March 31, 2025? | Categorical | | | 3 months ago | |
Will Soleno raise additional capital by December 31, 2024? | Binary | | | 3 months ago | |
Will Soleno's stock exceed its 52-week high within a week after FDA decision? | Binary | | | 3 months ago | |
Will FDA approve Soleno's DCCR for Prader-Willi Syndrome by March 31, 2025? | Binary | | | 3 months ago | |
What will be Soleno's stock price by December 31, 2024? | Categorical | | | 3 months ago | |
Will Soleno announce a partnership or acquisition related to DCCR by June 30, 2025? | Binary | | | 3 months ago | |
Will FDA approve Soleno's DCCR tablets for Prader-Willi Syndrome by March 31, 2025? | Binary | | | 3 months ago | |
Will Soleno's stock price remain above its 52-week high by December 31, 2024? | Binary | | | 3 months ago | |
How will Soleno's stock perform relative to the biotech index by December 31, 2024? | Categorical | | | 3 months ago | |
DCCR FDA Approval for Prader-Willi Syndrome by March 31, 2025? | Binary | | | 3 months ago | |
Soleno Announces Partnership/Acquisition for DCCR by End of 2024? | Binary | | | 3 months ago | |
Outcome of FDA Decision on DCCR by March 31, 2025? | Categorical | | | 3 months ago | |
Soleno's Partner for DCCR Distribution by End of 2024? | Categorical | | | 3 months ago | |
Will Soleno Therapeutics' stock reach a new all-time high by end of 2024? | Binary | | | 3 months ago | |
Will Soleno Therapeutics receive a buyout offer by mid-2025? | Binary | | | 3 months ago | |
Will the FDA approve SpringWorks' NDA for Mirdametinib for NF1-PN by the end of 2024? | Binary | | | 4 months ago | |
Will SpringWorks Therapeutics' stock increase by at least 5% within one week after FDA decision on Mirdametinib? | Binary | | | 4 months ago | |
What strategic business move will Soleno make following FDA review by June 30, 2025? | Categorical | | | 3 months ago | |
Will Soleno's DCCR tablets receive FDA approval by March 31, 2025? | Binary | | | 3 months ago | |
How will Soleno's stock react within a week of FDA's decision on DCCR? | Categorical | | | 3 months ago | |
How will the market react to FDA's decision on Soleno's DCCR tablets within one week? | Categorical | | | 3 months ago | |
What will be the outcome of FDA's priority review for Soleno's DCCR tablets by March 31, 2025? | Categorical | | | 3 months ago | |
Soleno Stock Increase Over 20% Within One Week of FDA Decision? | Binary | | | 3 months ago | |
Soleno Stock Price Range One Month After FDA Decision? | Categorical | | | 3 months ago | |
What will be the market outcome of Soleno's DCCR tablets by end of 2025? | Categorical | | | 3 months ago | |
What will be Soleno Therapeutics' next major strategic move by end of 2025? | Categorical | | | 3 months ago | |
How will Soleno's stock react within a week of FDA approval decision? | Categorical | | | 3 months ago | |
How will SpringWorks Therapeutics' stock react within one week after FDA decision on Mirdametinib? | Categorical | | | 4 months ago | |
How will Soleno Therapeutics' stock react within one week after FDA decision on DCCR? | Categorical | | | 4 months ago | |
What will be the outcome of the FDA AdComm meeting on Soleno's NDA for DCCR by December 27, 2024? | Categorical | | | 4 months ago | |
